Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Ede
Clinical trial register · Netherlands

Clinical Trials in Ede, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Netherlands and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3171 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:17 UTC
3171
Studies in scope
all four open statuses
1789
Recruiting now
open to new participants
601
Lead sponsors
across recruiting studies
Top sites
Amsterdam 1239 Rotterdam 853 Groningen 601 Nijmegen 565 Utrecht 543
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Radboud University Medical Center4 Wageningen University4 Stichting Hemato-Oncologie voor Volwassenen Nederland4 Merck Sharp & Dohme LLC4 AstraZeneca3 Eli Lilly and Company2 University Medical Center Groningen2 Erasmus Medical Center2 BioAegis Therapeutics Inc.1 Karakter Kinder- en Jeugdpsychiatrie1 Leiden University Medical Center1 Dutch Society of Physicians for Pulmonology and Tuberculosis1 Rijnstate Hospital1 Ionis Pharmaceuticals, Inc.1 Prospective Bladder Cancer Infrastructure Foundation1 CeleCor Therapeutics1 Alnylam Pharmaceuticals1 HAN University of Applied Sciences1 Association NVALT Studies1 Pfizer1 Maastricht Radiation Oncology1 Population Health Research Institute1 Novo Nordisk A/S1 Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 J.M. ten Berg1 Gilead Sciences1 Gelderse Vallei Hospital1 ARH van Zanten, MD PhD1 NewAmsterdam Pharma1 UMC Utrecht1 Melanoma and Skin Cancer Trials Limited1 dr.Frank L.J. Visseren1 The Netherlands Cancer Institute1
Site location
Amsterdam1239 Rotterdam853 Groningen601 Nijmegen565 Utrecht543 Maastricht420 Leiden385 Eindhoven208 Arnhem182 Breda172 Nieuwegein149 The Hague121 's-Hertogenbosch119 Tilburg114 Zwolle109 Enschede107 Dordrecht103 Amersfoort96 Leeuwarden87 Alkmaar86 Heerlen65 Delft60 Deventer59 Apeldoorn52 Almelo51 Ede50 Almere Stad49 Hilversum42 Hoofddorp41 Harderwijk39 Veldhoven26 Beverwijk22 Haarlem22 Venlo21 Doetinchem20 Sittard-Geleen18 Amstelveen18 Emmen17 Geleen16 Wageningen16 Hengelo16 Leidschendam15 Gouda14 Helmond14 Hoorn14 Goes14 Leiderdorp13 Assen13 Roosendaal13 Sittard12 Dirksland12 Uden12 Schiedam11 Amsterdam-Zuidoost11 Geldrop10 Sneek9 Heeze9 Zutphen9 Capelle aan den IJssel8 Bergen op Zoom8 Bilthoven7 Zaandam7 Hoogeveen7 Blaricum7 Zoetermeer6 Terneuzen6 Halsteren6 Zwijndrecht5 Born5 Scheemda5 Heemstede5 Ubbergen5 Tiel5 Boxmeer4 Drachten4 Multiple Locations4 Zeist4 Boekel3 GE Rotterdam3 Roermond3 Oegstgeest3 Velp3 Heerenveen3 Brunssum2 Flushing2 Waalwijk2 Warnsveld2 Gorinchem2 Purmerend2 Oss2 Hardenberg2 Doorn2 Heerjansdam1 Mill1 Hoensbroek1 Woerden1 Eersel1 Rosmalen1 Valkenswaard1 Vlijmen1 Amsterdam, Noord-Holland1 Zuidlaren1 Balkbrug1 Goes/Vlissingen1 Deurne1 Leuven1 Friesland1 Many Locations1 Den Helder1 Heerhugowaard1 Westzeedijk 3531 Holland1 Zeeland1 Winterswijk1 Weert1 Haps1 Valkenburg1 Heemskerk1 EJ Eindhoven1 Zetten1 Ermelo1 Waalre1 Venray1 Wijk aan Zee1 Sgravenhage1 Doedrecht1 Geert Grooteplein-Zuid 81 Diemen1 HEERLENHeerlen1 Apeldoorn & Zutphen1 Eindhoven & Veldhoven1 Groningen de Brug1 Alphen aan den Rijn1 Hazerswoude-Rijndijk1 's-Gravenhage (Den Haag, the Hague)1 Beek1 Santpoort-Noord1 Maastrich1 Hoogenveen, Emmen, Stadskanaal1 Zutphens1 Baarn1 Meppel1 Beetsterzwaag1 Groesbeek1 Rotterrdam1 Etten-Leur1 Sittard Geleen1 Nederland1 Hengstdal1 Rijswijk1 Limburg1 Lochem1 IJsselstein1 Vianen1 Naarden1 Elst1 Schiphol1 Christchurch1 Lower Hutt1 Tauranga1 Wellington1 Vught1 Almere1 NL -rotterdam1
All 164 locations
Target enrolment
to

Trials with a site in Ede

50 of 3171 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Netherlands
Start
Recruiting
Wageningen University
Not applicable
30
Ede
2026-07-18
Recruiting
Merck Sharp & Dohme LLC
Phase 2
750
Ede, Harderwijk, Roosendaal, Alkmaar, Sneek, Dordrecht, Groningen
2026-06-30
Recruiting
Novo Nordisk A/S
Phase 3
5,610
's-Hertogenbosch, Amsterdam, Beverwijk, Breda, Dirksland, Ede, Eindhoven, Gouda
2026-05-11
Recruiting
The TASTY-training Study
NCT07258589Oncological Patients, Tyrosine Kinase Inhibitor
University Medical Center Groningen
Not applicable
90
Amsterdam, Arnhem, Dirksland, Ede, Groningen, Nijmegen, Rotterdam, Scheemda
2025-11-10
Recruiting
Radboud University Medical Center
Not applicable
735
Arnhem, Doetinchem, Ede, Nijmegen, Winterswijk, 's-Hertogenbosch, Breda, Eindhoven
2025-10-23
Recruiting
ARH van Zanten, MD PhD
Observational
200
Ede
2025-10-13
Recruiting
Gelderse Vallei Hospital
Not applicable
124
Ede, Deventer, Enschede, Groningen, The Hague
2025-09-30
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
's-Hertogenbosch, Alkmaar, Amersfoort, Amsterdam, Doetinchem, Ede, Goes, Hoogeveen
2025-09-06
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Alkmaar, Almere Stad, Amersfoort, Amsterdam, Arnhem, Born, Ede, Hilversum
2025-09-02
Recruiting
Prospective Data Collection Initiative on Thoracic Malignancies
NCT06996249Lung Cancer, Thoracic Cancer, Lung Cancer, Nonsmall Cell, Adenocarcinoma
Dutch Society of Physicians for Pulmonology and Tuberculosis
Observational
12,000
Ede, Eindhoven, Hilversum, Utrecht, Alkmaar, Amersfoort, Amsterdam, Breda
2025-08-15
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
360
Ede, Nijmegen, Drachten
2025-07-03
Recruiting
The TASTY-steering Study
NCT07258563Metastatic Triple Negative Breast Cancer, Metastatic Testicular Cancer, Stage II-IV Diffuse Large B Cell Lymphoma
University Medical Center Groningen
Not applicable
201
Amsterdam, Arnhem, Dirksland, Ede, Groningen, Nijmegen, Rotterdam, Scheemda
2025-06-06
Recruiting
AstraZeneca
Phase 3
11,300
's-Hertogenbosch, Almelo, Amsterdam, Born, Deventer, Ede, Enschede, Haarlem
2025-03-14
Recruiting
Effectiveness of Decision Support for Cardiovascular Risk Management in People With Cardiovascular Disease
NCT06871514Atherosclerotic Cardiovascular Diseases, Shared-decision Making
dr.Frank L.J. Visseren
Not applicable
1,200
Alkmaar, Amersfoort, Deventer, Ede, Nijmegen, The Hague, Utrecht
2025-02-18
Recruiting
AstraZeneca
Phase 3
1,160
Alkmaar, Ede, Groningen, Leidschendam, Veldhoven
2024-11-27
Recruiting
AstraZeneca
Phase 3
1,160
Alkmaar, Ede, Groningen, Leidschendam, Veldhoven, Zwolle
2024-11-18
Recruiting
Wageningen University
Not applicable
40
Arnhem, Ede
2024-10-22
Recruiting
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
NCT05947955Acute Respiratory Distress Syndrome, Infections
BioAegis Therapeutics Inc.
Phase 2
600
's-Hertogenbosch, Apeldoorn, Ede, Enschede, Nijmegen
2024-10-03
Recruiting
Screening for Malnutrition in Obese Patients
NCT06626360Overweight and Obese Adults, Malnutrition or Risk of Malnutrition
HAN University of Applied Sciences
Observational
2,000
Amsterdam, Ede, Rotterdam
2024-10-02
Recruiting
Wageningen University
Not applicable
102
Arnhem, Ede
2024-09-01
Recruiting
Merck Sharp & Dohme LLC
Phase 3
348
Ede, Harderwijk, Hengelo, Zwolle, Utrecht
2024-05-24
Recruiting
Erasmus Medical Center
Not applicable
260
Rotterdam, Alkmaar, Breda, Dordrecht, Ede, Eindhoven
2024-04-23
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 1/2
112
's-Hertogenbosch, Alkmaar, Amersfoort, Amsterdam, Dordrecht, Ede, Eindhoven, Groningen
2024-04-15
Recruiting
Radboud University Medical Center
Not applicable
690
Hilversum, Amsterdam, Apeldoorn & Zutphen, Breda, Deventer, Ede, Eindhoven & Veldhoven, Emmen
2024-03-19
Active, closed
Eli Lilly and Company
Phase 3
17,300
Amersfoort, Amsterdam, Apeldoorn, Beverwijk, Delft, Deventer, Doetinchem, Ede
2024-03-05
Recruiting
Radboud University Medical Center
Not applicable
360
's-Hertogenbosch, Almelo, Amersfoort, Amsterdam, Arnhem, Boxmeer, Ede, Emmen
2023-12-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Emmen, Hoogeveen, Apeldoorn, Doetinchem, Ede, Harderwijk, Nijmegen, Tiel
2023-10-09
Active, closed
MAD Trial: Myopia Atropine Dose
NCT05667454Progressive Myopia
Erasmus Medical Center
Phase 3
550
Almere Stad, Amsterdam, Delft, Deventer, Dordrecht, Ede, Goes, Heerenveen
2022-12-19
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
885
Amsterdam, Apeldoorn, Arnhem, Dirksland, Ede, Hoogeveen, Nijmegen, Rotterdam
2022-12-13
Active, closed
Gilead Sciences
Phase 3
1,021
Breda, Ede, Groningen, Harderwijk, Tilburg
2022-10-12
Recruiting
Equine-assisted Therapy for Therapy-resistant Adolescents With Autism Spectrum Disorders, a Replicated AB-design
NCT05200351Emotion Regulation, Autism Spectrum Disorder, Adolescent - Emotional Problem
Karakter Kinder- en Jeugdpsychiatrie
Not applicable
35
Ede, Heerjansdam, Mill
2022-02-14
Active, closed
NewAmsterdam Pharma
Phase 3
9,541
Amsterdam, Arnhem, Beverwijk, Delft, Dirksland, Dordrecht, Ede, Eindhoven
2022-02-07
Active, closed
Association NVALT Studies
Phase 3
170
Almelo, Amsterdam, Arnhem, Ede, Eindhoven, Flushing, Groningen, Maastricht
2021-12-06
Active, closed
Leiden Thrombosis Recurrence Risk Prevention
NCT06087952Venous Thromboembolism, Venous Thromboses, Pulmonary Embolism, Deep Vein Thrombosis
Leiden University Medical Center
Not applicable
608
Leiden, Amsterdam, Assen, Beverwijk, Breda, Deventer, Drachten, Ede
2021-06-18
Active, closed
A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI
NCT04825743ST-elevation Myocardial Infarction (STEMI)
CeleCor Therapeutics
Phase 3
2,463
Heerlen, 's-Hertogenbosch, Amsterdam, Arnhem, Blaricum, Breda, Doetinchem, Ede
2021-04-24
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
5,000
Almelo, Amersfoort, Amsterdam, Arnhem, Breda, Dordrecht, Ede, Eindhoven
2021-01-15
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
85
Almere Stad, Amersfoort, Amsterdam, Dordrecht, Ede, Eindhoven, Enschede, Gouda
2020-12-29
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
60
's-Hertogenbosch, Amsterdam, Arnhem, Breda, Delft, Dordrecht, Ede, Eindhoven
2020-12-23
Recruiting
Prospective Bladder Cancer Infrastructure Foundation
Observational
3,600
's-Hertogenbosch, Almelo, Amersfoort, Amsterdam, Arnhem, Breda, Dordrecht, Ede
2020-10-04
Recruiting
Rijnstate Hospital
Observational
194
Nijmegen, Apeldoorn, Deventer, Ede, Enschede, Veldhoven
2020-06-12
Active, closed
Natural Course of Pain Following Surgery Through an Abdominal Incision
NCT04088838Adhesions Abdominal, Adhesions Pelvic, Surgery Induced Tissue Adhesions, Chronic Pain
Radboud University Medical Center
Observational
650
Boxmeer, Nijmegen, Maastricht, Arnhem, Doetinchem, Ede
2020-01-01
Recruiting
Melanoma and Skin Cancer Trials Limited
Not applicable
2,998
Almere Stad, Ede, Zutphen, Eindhoven, Groningen, Heerlen, Maastricht, Utrecht
2019-12-17
Recruiting
Population Health Research Institute
Phase 4
2,270
's-Hertogenbosch, Alkmaar, Almelo, Amstelveen, Arnhem, Breda, Deventer, Ede
2019-06-14
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
109
's-Hertogenbosch, Amersfoort, Amsterdam, Apeldoorn, Breda, Delft, Dordrecht, Ede
2018-08-30
Active, closed
Maastricht Radiation Oncology
Observational
180
Almelo, Apeldoorn, Arnhem, Deventer, Ede, Eindhoven, Enschede, Gorinchem
2016-07
Recruiting
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
NCT02735707Respiratory Tract Diseases, Influenza (Pandemic), Influenza, Community Acquired Pneumonia
DrugsConvalescent plasma·Repagermanium·Ivermectin·Telmisartan
UMC Utrecht
Phase 3
20,000
Utrecht, 's-Hertogenbosch, Almelo, Amersfoort, Amsterdam, Arnhem, Deventer, Ede
2016-04-11
Recruiting
Future Optimal Research and Care Evaluation
NCT03823547Acute Coronary Syndrome, Myocardial Infarction
J.M. ten Berg
Observational
99,999
Apeldoorn, Arnhem, Ede, Tiel
2015-01-01
Active, closed
Pfizer
Phase 3
1,068
Amsterdam, Ede, Eindhoven, Groningen, Leeuwarden, Maastricht, Sneek
2014-12-17
Active, closed
The COLON Study: Colorectal Cancer Cohort
NCT03191110Colorectal Neoplasms Malignant
Wageningen University
Observational
2,000
Almelo, Apeldoorn, Arnhem, Doetinchem, Ede, Goes/Vlissingen, Groningen, Nijmegen
2010-08-03
Active, closed
The Netherlands Cancer Institute
Phase 2/3
310
Alkmaar, Amsterdam, Delft, Deventer, Dordrecht, Ede, Haarlem, Heerlen
2010-01
Rows per page Showing 1–50 of 50
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Dutch investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-netherlands/city/ede

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Netherlands and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,171 studies in total at the last sync on 10 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 50 of those studies with a site in Ede.

How many clinical trials are recruiting in Ede?

33 of the 50 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 17 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ede), 50 studies
PhaseStudiesRecruitingShare
Phase 317834%
Not applicable141328%
Observational10620%
Phase 25310%
Phase 1/2224%
Phase 2/3102%
Phase 4112%

Most active sponsors

Lead sponsors with the most studies (Ede)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC43
Radboud University Medical Center43
Stichting Hemato-Oncologie voor Volwassenen Nederland42
Wageningen University43
AstraZeneca33
Eli Lilly and Company21
Erasmus Medical Center21
University Medical Center Groningen22
Alnylam Pharmaceuticals11
ARH van Zanten, MD PhD11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.